1. HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9. (30th June 2018) Authors: Chen, Dong-qin; Yu, Chen; Zhang, Xue-feng; Liu, Zhong-fang; Wang, Rui; Jiang, Min; Chen, Hao; Yan, Feng; Tao, Min; Chen, Long-bang; Zhu, Hong; Feng, Ji-feng Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗